本网站销售的所有产品仅用于工业应用或者科学研究等非医疗目的，不可用于人类或动物的临床诊断或者治疗，非药用，非食用。
帕妥珠单抗
英文名：Pertuzumab
Cas号：380610-27-5
Cas号：380610-27-5
检测信息查询
| 别 名 | 帕妥株单抗;帕妥珠单抗 |
| Cas号 | 380610-27-5 |
| M D L | |
| 分子式 | C17H27NO2 |
| 分子量 | 277.40178 |
| 产品参数 | Description
Pertuzumab, a humanized monoclonal antibody, is a HER2 dimerization inhibitor for the treatment of metastatic HER2-positive breast cancer. IC50 & Target EGFR[1] Storage Please store the product under the recommended conditions in the Certificate of Analysis. References [1]. Nahta R, et al. The HER-2-targeting antibodies trastuzumab and pertuzumab synergistically inhibit the survivalof breast cancer cells. Cancer Res. 2004 Apr 1;64(7):2343-6. [2]. Scheuer W, et al. Strongly enhanced antitumor activity of trastuzumab and pertuzumab combination treatment on HER2-positive human xenograft tumor models. Cancer Res. 2009 Dec 15;69(24):9330-6. |
| 性状 | Pertuzumab 是一种人源化单克隆抗体，是一种HER2二聚抑制剂。可用于治疗转移性HER2 阳性乳腺癌。 |
| 贮存 |
沪公网安备 31012002003054号